Project Grant R44CA295373
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$1.1M
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Nicholasville, KY 40356, USA
Similar Awards
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to Radiopharmaceutical Imaging And Dosimetry, LLC provides $1,003,173 to develop a prototype web/cloud-based quantitative SPECT reconstruction software system for clinical trials and dosimetry of radiopharmaceutical therapy (RPT) using alpha-emitting radionuclides. The goal is to create advanced quantitative imaging capabilities to support the precision medicine approach required for...
This Project Grant from the National Science Foundation Division of Mathematical Sciences supports the development of a generalizable data framework to enable precision radiotherapy for individual cancer patients. Funded at $104,016 under the Mathematical and Physical Sciences program (CFDA 47.049), the award will support collaborative research between Jackson Laboratory and other organizations to build and validate a deep reinforcement learning model using multimodal imaging data from cancer...
This federal Project Grant award of $644,622 from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) aims to enhance radioligand therapy for prostate cancer through the development of biomarker and dosimetry-guided personalized treatment approaches. The key objectives are to: 1) develop a novel method for bone marrow dosimetry using macro/micro Monte Carlo modeling, 2) build predictive models to estimate absorbed radiation doses from pre-therapy PET...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $158,899 to Emory University to develop an innovative platform for conformal flash proton therapy to treat central lung cancer. The key products and services to be delivered include: Establishing a Simultaneous Intensity Energy Modulation and Compensation (SIEMAC) optimization platform to inversely solve the variables (intensity and energy) of the Integrated Physical Optimization...
This Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) provides $613,827 to Mayo Clinic Arizona to conduct research on improving radiation therapy delivery models and minimizing adverse events in spot scanning proton therapy. The key products and services to be delivered include: Developing a novel "Dose-LET Volume Histogram" tool to visualize and analyze the relationship between radiation dose, linear energy transfer (LET), and...
The National Cancer Institute (NCI) awarded a $898,497 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Radiopharmaceutical Imaging and Dosimetry, LLC to develop a cloud-based, customer-responsive dosimetry tool for alpha-particle emitting radiopharmaceutical therapies. The key objectives are to: 1) establish a library of microscale S-values and apportionment factors for dose-limiting tissues, 2) implement a macro-to-micro dosimetry methodology to enable...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop an innovative radiation imaging tool to support the advancement of targeted alpha cancer therapies. The $811,503 award to Qscint Imaging Solutions LLC, located in Tucson, AZ, will fund the refinement of an algorithm for real-time isotopic spectroscopy...
The federal Project Grant award R21CA294042 from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports research to develop a radiotheranostic approach for treating glioblastoma (GBM) and other IL13RA2-expressing cancers. The primary objectives are to establish in vitro assays to validate target specificity and assess binding kinetics, stability, and radiation toxicity of radiolabeled antibodies targeting IL13RA2, as well as to develop and compare the efficacy of...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to M3D, Inc. will develop a novel gamma-ray radiation imager for image-guided tumor diagnostics. The goal is to create a system capable of rapidly and accurately detecting gamma-ray emitting radiotracers used to identify the location of lymph nodes and tumor drainage during cancer surgical procedures. The project will characterize the design parameters of the...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $695,814 to Mayo Clinic Arizona to develop AI-powered technologies that enable online adaptive proton therapy for head and neck cancer treatment. The key products and services to be delivered include: An asymmetric autoencoder network with vision-transformer...